Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
| Revenue (Most Recent Fiscal Year) | $9.87B |
| Net Income (Most Recent Fiscal Year) | $871.00M |
| PE Ratio (Current Year Earnings Estimate) | 18.42 |
| PE Ratio (Trailing 12 Months) | 19.65 |
| PEG Ratio (Long Term Growth Estimate) | 2.49 |
| Price to Sales Ratio (Trailing 12 Months) | 1.96 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.86 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 13.23 |
| Pre-Tax Margin (Trailing 12 Months) | 11.67% |
| Net Margin (Trailing 12 Months) | 8.81% |
| Return on Equity (Trailing 12 Months) | 15.11% |
| Return on Assets (Trailing 12 Months) | 6.65% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.44 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.31 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.84 |
| Inventory Turnover (Trailing 12 Months) | 36.73 |
| Book Value per Share (Most Recent Fiscal Quarter) | $61.38 |
| Earnings per Share (Most Recent Fiscal Quarter) | $2.21 |
| Earnings per Share (Most Recent Fiscal Year) | $8.93 |
| Diluted Earnings per Share (Trailing 12 Months) | $7.91 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 111.64M |
| Free Float | 102.53M |
| Market Capitalization | $19.94B |
| Average Volume (Last 20 Days) | 0.78M |
| Beta (Past 60 Months) | 0.49 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 8.16% |
| Percentage Held By Institutions (Latest 13F Reports) | 88.06% |
| Annual Dividend (Based on Last Quarter) | $3.20 |
| Dividend Yield (Based on Last Quarter) | 1.79% |